3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
7
cemiplimab
6
Nivolumab
5
avelumab
3
encorafenib
2
binimetinib
2
Radiotherapy
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Blood Specimen Collection
2
toripalimab
1
tislelizumab
1
lifileucel
1
lenvatinib
1
durvalumab
1
dostarlimab
1
cobimetinib
1
atezolizumab
1
Vemurafenib
1
Surveys and Questionnaires
1
Sirolimus
1
Radiosurgery
1
Prednisone
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Mohs Surgery
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Skin Neoplasms
×
Biopsy, Large-Core Needle
×
Clear all
NCT05520099
2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
416 enrolled